Share on PinterestGLP-1 drugmaker Eli Lilly’s new weight loss pill orforglipron showed meaningful weight loss results in a recent clinical trial. Scott Olson/Getty Images Eli Lilly’s new oral GLP-1 medication orforglipron produced an average weight loss of 12.4% (27.3 pounds) in clinical trials. The weight loss pill also significantly improved heart health markers like cholesterol... Read More














:max_bytes(150000):strip_icc()/HDC-GettyImages-668641904-9179dc9fe60446d8b4d8a08fbffcf46d.jpg?w=600&resize=600,400&ssl=1)


:max_bytes(150000):strip_icc():format(jpeg)/Health-GettyImages-1484341547-2b72e64020e84487bb504cbe25299d4e.jpg?w=600&resize=600,400&ssl=1)
Recent Comments